Dilatation Therapy and Demographic Characteristics Significantly Influence the Amount of Propofol for Therapeutic Endoscopic Retrograde Cholangiography

Schmidt, Christoph A.; Keil, Carsten; Kirstein, Martha M.; Lehner, Frank; Manns, Michael P.; von Hahn, Thomas; Lankisch, Tim O.; Voigtländer, Torsten

doi:10.1155/2019/4793096

Dilatation Therapy and Demographic Characteristics Significantly Influence the Amount of Propofol for Therapeutic Endoscopic Retrograde Cholangiography

Clicks: 349

ID: 10571

2019

Free PDF

Article Quality & Performance Metrics

Overall Quality

Not rated

Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.

Reader Engagement Emerging Content

69.8 /100

349 views

276 readers

AI Quality Assessment

Not analyzed

Readership in this journal

Emerging

Ranked #3 of 25 articles by views in international journal of hepatology

Mint this article as an NFT

Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required

Sign in to mint

Abstract

EN
- Turkish
- Spanish
- Portuguese
- Arabic
- Chinese
- French
- German
- Indonesian
- Russian
- Thai

Background and Study Aims. Patients undergoing therapeutic endoscopic retrograde cholangiography (ERC) may require different amounts of sedative agents depending on demographic characteristics, indication of ERC, and/or endoscopic intervention. Patients and Methods. We retrospectively analyzed all patients undergoing therapeutic ERC from 2008 – 2014 who received deep sedation with propofol ± midazolam. Results. A total of 2448 ERC procedures were performed in 781 patients. The cumulative per procedure propofol dose in the different groups was as follows: PSC 479 mg (±256), bile duct stones 356 mg (±187), benign stenosis/cholestasis 395 mg (±228), malignant stenosis 401 mg (±283), and postliver transplant complications 391 mg (±223) (p < 0.05). Multivariable analysis showed that dilatation therapy

Abstract Quality Issue: This abstract appears to be incomplete or contains metadata (109 words). Try re-searching for a better abstract.

Reference Key	a2019dilatationinternational Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors	Christoph A. Schmidt, Carsten Keil, Martha M. Kirstein, Frank Lehner, Michael P. Manns, Thomas von Hahn, Tim O. Lankisch, Torsten Voigtländer Are you one of these authors? Claim your profile
Journal	international journal of hepatology
Year	2019
DOI	10.1155/2019/4793096 Searching for DOI...
URL	https://www.hindawi.com/journals/ijh/2019/4793096/abs/ https://doi.org/10.1155/2019/4793096
Keywords	Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

Login to comment Register

No comments yet. Be the first to comment on this article.